|
HSPD1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.65110000000168E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.185500E-04 |
| Normal-vs-Stage2 |
3.959100E-03 |
| Normal-vs-Stage3 |
1.40999999997948E-06 |
| Normal-vs-Stage4 |
9.324400E-02 |
| Stage1-vs-Stage2 |
7.629400E-01 |
| Stage1-vs-Stage3 |
4.140400E-02 |
| Stage1-vs-Stage4 |
5.816800E-01 |
| Stage2-vs-Stage3 |
2.911200E-01 |
| Stage2-vs-Stage4 |
5.210800E-01 |
| Stage3-vs-Stage4 |
1.203420E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.33890000000048E-05 |
| Normal-vs-AfricanAmerican |
4.27940000000682E-05 |
| Normal-vs-Asian |
3.322000E-01 |
| Caucasian-vs-AfricanAmerican |
2.234000E-01 |
| Caucasian-vs-Asian |
6.666200E-01 |
| AfricanAmerican-vs-Asian |
3.166000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.5427999999762E-06 |
| Normal-vs-Female |
1.704290E-02 |
| Male-vs-Female |
8.518400E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.042500E-04 |
| Normal-vs-Age(41-60Yrs) |
5.53359999999614E-05 |
| Normal-vs-Age(61-80Yrs) |
4.984200E-04 |
| Normal-vs-Age(81-100Yrs) |
3.076600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.401000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.848200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.392200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.831200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.651600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.775800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.100040E-02 |
| Normal-vs-Grade 2 |
2.011500E-04 |
| Normal-vs-Grade 3 |
3.386700E-04 |
| Normal-vs-Grade 4 |
9.675900E-03 |
| Grade 1-vs-Grade 2 |
4.638600E-01 |
| Grade 1-vs-Grade 3 |
5.884600E-01 |
| Grade 1-vs-Grade 4 |
7.978200E-01 |
| Grade 2-vs-Grade 3 |
7.343400E-01 |
| Grade 2-vs-Grade 4 |
5.746200E-01 |
| Grade 3-vs-Grade 4 |
6.900200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.317600E-02 |
| Normal-vs-ccB subtype |
7.5188000048243E-08 |
| ccA subtype-vs-ccB subtype |
1.52286999999252E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62485999999351E-05 |
| Normal-vs-N1 |
2.123400E-01 |
| N0-vs-N1 |
7.445200E-01 |
|
|
